BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22178947)

  • 1. Cholesterol depletion with (2-hydroxypropyl)- β-cyclodextrin modifies the gating of membrane electroporation-induced inward current in pituitary tumor GH3 cells: experimental and analytical studies.
    Wu SN; Yeh CC; Huang HC; Yang WH
    Cell Physiol Biochem; 2011; 28(5):959-68. PubMed ID: 22178947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in membrane cholesterol of pituitary tumor (GH3) cells regulate the activity of large-conductance Ca2+-activated K+ channels.
    Lin MW; Wu AZ; Ting WH; Li CL; Cheng KS; Wu SN
    Chin J Physiol; 2006 Feb; 49(1):1-13. PubMed ID: 16900700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations into the correlation properties of membrane electroporation-induced inward currents: prediction of pore formation.
    Wu SN; Yeh CC; Wu PY; Huang HC; Tsai ML
    Cell Biochem Biophys; 2012 Jan; 62(1):211-20. PubMed ID: 21928108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in membrane biophysical properties induced by the Budesonide/Hydroxypropyl-β-cyclodextrin complex.
    Dos Santos AG; Bayiha JC; Dufour G; Cataldo D; Evrard B; Silva LC; Deleu M; Mingeot-Leclercq MP
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1930-1940. PubMed ID: 28642042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of memantine, an NMDA-receptor antagonist, on electroporation-induced inward currents in pituitary GH3 cells.
    Wu SN; Huang HC; Yeh CC; Yang WH; Lo YC
    Biochem Biophys Res Commun; 2011 Feb; 405(3):508-13. PubMed ID: 21262200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Kv7.2/Kv7.3 channels by cholesterol: Relevance of an optimum plasma membrane cholesterol content.
    Delgado-Ramírez M; Sánchez-Armass S; Meza U; Rodríguez-Menchaca AA
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1242-1251. PubMed ID: 29474891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-beta-cyclodextrin reversibly alters the gating of lipid rafts-associated Kv1.3 channels in Jurkat T lymphocytes.
    Pottosin II; Valencia-Cruz G; Bonales-Alatorre E; Shabala SN; Dobrovinskaya OR
    Pflugers Arch; 2007 May; 454(2):235-44. PubMed ID: 17242956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
    Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
    Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy.
    Song W; Wang F; Lotfi P; Sardiello M; Segatori L
    J Biol Chem; 2014 Apr; 289(14):10211-22. PubMed ID: 24558044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells.
    Pouvreau S; Berthier C; Blaineau S; Amsellem J; Coronado R; Strube C
    J Physiol; 2004 Mar; 555(Pt 2):365-81. PubMed ID: 14724204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol modifies the gating of Kv1.3 in human T lymphocytes.
    Hajdú P; Varga Z; Pieri C; Panyi G; Gáspár R
    Pflugers Arch; 2003 Mar; 445(6):674-82. PubMed ID: 12632187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-β-cyclodextrin.
    Crumling MA; Liu L; Thomas PV; Benson J; Kanicki A; Kabara L; Hälsey K; Dolan D; Duncan RK
    PLoS One; 2012; 7(12):e53280. PubMed ID: 23285273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease.
    Ward S; O'Donnell P; Fernandez S; Vite CH
    Pediatr Res; 2010 Jul; 68(1):52-6. PubMed ID: 20357695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoprotection of pancreatic β-cells and hypoglycemic effect of 2-hydroxypropyl-β-cyclodextrin: sertraline complex in alloxan-induced diabetic rats.
    Buko V; Zavodnik I; Lukivskaya O; Naruta E; Palecz B; Belica-Pacha S; Belonovskaya E; Kranc R; Abakumov V
    Chem Biol Interact; 2016 Jan; 244():105-12. PubMed ID: 26593071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory actions of di-8-butyl-amino-naphthyl-ethylene-pyridinium-propyl-sulfonate (di-8-ANEPPS), voltage-sensitive dye, on the BKCa channel in pituitary tumor (GH3) cells.
    Wu SN; Lin MW; Wang YJ
    Pflugers Arch; 2008 Jan; 455(4):687-99. PubMed ID: 17701422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple regulatory actions of 2-guanidine-4-methylquinazoline (GMQ), an agonist of acid-sensing ion channel type 3, on ionic currents in pituitary GH
    So EC; Wang Y; Yang LQ; So KH; Lo YC; Wu SN
    Biochem Pharmacol; 2018 May; 151():79-88. PubMed ID: 29477572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical study of structures and charge distributions of 2-, 3- and 6-hydroxypropyl-β-cyclodextrin with different degrees of substitution.
    Alvira E
    J Biomol Struct Dyn; 2023 Dec; 41(20):10582-10590. PubMed ID: 36524475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system.
    Aytac Z; Sen HS; Durgun E; Uyar T
    Colloids Surf B Biointerfaces; 2015 Apr; 128():331-338. PubMed ID: 25769282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of simvastatin into lipid membranes: Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin.
    Bartkowiak A; Matyszewska D; Krzak A; Zaborowska M; Broniatowski M; Bilewicz R
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111784. PubMed ID: 33984617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast Cancer.
    Saha ST; Abdulla N; Zininga T; Shonhai A; Wadee R; Kaur M
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.